CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Tumor-associated macrophages and epithelial�mesenchymal transition in cancer: Nanotechnology comes into view
Authors
R. Faridi-Majidi
M.R. Jaafari
+5 more
H. Mirzaei
R. Mombeiny
A. Salmaninejad
S.M.R. Sorkhabadi
R. Vakili-Ghartavol
Publication date
1 January 2018
Publisher
Abstract
Tumor-associated macrophages (TAMs) are an important component of the leukocytic infiltrate of the tumor microenvironment. There is persuasive preclinical and clinical evidence that TAMs induce cancer inanition and malignant progression of primary tumors toward a metastatic state through a highly conserved and fundamental process known as epithelial�mesenchymal transition (EMT). Tumor cells undergoing EMT are distinguished by increased motility and invasiveness, which enable them to spread to distant sites and form metastases. In addition, besides becoming resistant to apoptosis and antitumor drugs, they also contribute to immunosuppression and get a cancer stem-cell like phenotype. Here, we will focus on selected molecular pathways underlying EMT�in particular, the role of TAMs in the induction and maintenance of EMT�and further discuss how the targeting of TAMs through the application of nanotechnology tools allows the development of a whole new range of therapeutics. © 2018 Wiley Periodicals, Inc
Similar works
Full text
Available Versions
eprints Iran University of Medical Sciences
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:eprints.iums.ac.ir:6983
Last time updated on 10/10/2019